Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Synthetic Human Secretin in Children With Autism

ClinicalTrials.gov ID: NCT00036244

Public ClinicalTrials.gov record NCT00036244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.

Study identification

NCT ID
NCT00036244
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Repligen Corporation
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
32 Months to 59 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2002 (Type not available)
Primary completion
Not listed
Completion
Jan 2004 (Type not available)
Last update posted
Aug 5, 2005

2002 – 2004

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Southwest Autism Research Center Phoenix Arizona — —
UCLA Pediatric Neurology Los Angeles California 90095-1752 —
Children's Hospital and Research Center at Oakland Oakland California 94609 —
1st Allergy & Clinical Research Center Centennial Colorado 80112 —
Alachua Family Psychiatry Gainesville Florida 32607 —
Miami Children's Hospital Miami Florida — —
Riley Children's Hospital Indianapolis Indiana 46202-5200 —
The Clinical Trials Center:A Division of Children's Hospital Metairie Louisiana 70006 —
Hardy Healthcare Associates Hingham Massachusetts — —
Children's Hospital of Michigan Detroit Michigan 48201 —
University of Medicine and Dentistry of New Jersey Newark New Jersey 07107 —
Schneider Children's Hospital New Hyde Park New York — —
The Ohio State University Columbus Ohio 43210 —
Children's Biomedical Center of Utah Sandy City Utah 84093 —
Puget Sound Neurology Edmonds Washington 98026 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00036244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2005 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00036244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →